Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 1 6Phase 3 4Phase 4 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 2Suspended 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 1128Carcinoma, Non-Small-Cell Lung 718Neoplasms 545Prostatic Neoplasms 502Colorectal Neoplasms 438Multiple Myeloma 336Lung Neoplasms 309Neoplasm Metastasis 288Leukemia, Myeloid, Acute 263Stomach Neoplasms 248Carcinoma, Hepatocellular 245Ovarian Neoplasms 225Rectal Neoplasms 211Colonic Neoplasms 204Lymphoma, Follicular 200Lymphoma 199Leukemia 190Uterine Cervical Neoplasms 181Head and Neck Neoplasms 174Pancreatic Neoplasms 171Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Recurrence 161Melanoma 158Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Squamous Cell Carcinoma of Head and Neck 147Pain 141Urinary Bladder Neoplasms 139Brain Neoplasms 133

Interventions

relugolix 1Immunonutrition Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Endometriosis × Clear all
NCT04756037 2026-05-13

SERENE

Sumitomo Pharma Switzerland GmbH

Phase 3 Completed
1,164 enrolled 16 charts

Endometriosis, Leiomyoma

NCT05726786 2025-12-09

INCyst

Centre Hospitalier Universitaire Vaudois

Phase 3 Recruiting
232 enrolled
Genitourinary

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Endometriosis, Cystitis, Interstitial, Malnutrition

NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Sumitomo Pharma Switzerland GmbH

Phase 3 Recruiting
1,000 enrolled

Endometriosis, Leiomyoma, Myofibroma

NCT00865488 2009-12-23

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

OMRIX Biopharmaceuticals

Phase 3 Suspended
80 enrolled
Gynecologic

Tissue Adhesions, Endometriosis, Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡